Company / Revenue per Share
Adaptive Biotechnologies Corp Revenue per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$1.87
FY2025
5-year range
$1.12 / $1.87
FY2021-FY2025
Trend
+52.0%
vs FY2024
Sector context
#90 of 154
Health Care
What the data says
At $1.87, Adaptive Biotechnologies Corp's revenue per share ranks #90 of 154 in the Health Care sector. Revenue per Share has fluctuated over the past 9 years, ranging from $0.79 in FY2020 to $6.62 in FY2019.
Based on SEC 10-K filings.
1.87 in FY2025 with a 5-year CAGR of +19.0%.
Improved from $1.19 to $1.87 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +12.7%
- 5-Year CAGR
- +19.0%
- 10-Year CAGR
- -
Sector benchmark
#90 of 154 in Health CareTop 58% of 154This company $1.87 Sector average $10.35
▼
-81.9% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 52.0% year-over-year.
- Ranks #90 out of 154 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2019.
- Lowest revenue per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -1.45 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.87 | +52.0% |
| FY2024 | $1.23 | +3.7% |
| FY2023 | $1.19 | -9.2% |
| FY2022 | $1.31 | +16.9% |
| FY2021 | $1.12 | +42.7% |
| FY2020 | $0.79 | -88.1% |
| FY2019 | $6.62 | +50.3% |
| FY2018 | $4.41 | +39.8% |
| FY2017 | $3.15 | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026